BioMarin Pharma News, BioMarin Pharma Quote, BMRN Quote

BioMarin Pharma (NQ:BMRN) Delayed: 64.26 +0.32 (0.50%)

Prev. Close

$63.94

Today 6M 1Y 5Y

Open

$64.35

52 Wk High

$108.96

52 Wk Low

$62.12

Day High

$64.96

Day Low

$63.58

P/E

N/A

EPS

$-1.27

Volume

795,522

Friends, Peers and Foes (?): ALNY, IONS, VRTX, FOLD, VEEV (more...)

ALERTS | RSS

Sep 16, 2026 07:57 AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $97 at BMO Capital
Sep 15, 2026 08:34 AM BioMarin drops VOXZOGO development for Noonan syndrome children
Sep 15, 2026 08:32 AM Form 8-K BIOMARIN PHARMACEUTICAL For: Sep 15
Sep 14, 2026 06:55 PM Form 4 BIOMARIN PHARMACEUTICAL For: Sep 10 Filed by: Plenge Robert M
Sep 14, 2026 06:48 PM Form 3 BIOMARIN PHARMACEUTICAL For: Sep 10 Filed by: Plenge Robert M
Sep 14, 2026 09:26 AM Form 8-K BIOMARIN PHARMACEUTICAL For: Sep 10
Sep 14, 2026 09:05 AM BioMarin adds Bristol Myers Squibb research chief to its board
Sep 14, 2026 09:05 AM BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors
Sep 10, 2026 06:50 AM H.C. Wainwright Reiterates Neutral Rating on BioMarin Pharmaceutical Inc. (BMRN)
Sep 1, 2026 07:30 AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $90; Piper Sandler: 'Remain Buyers'

Entities mentioned with BMRN

View All Entities